Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:780-786
Published online before print February 9, 2006, doi: 10.1161/01.ATV.0000209517.00220.cd
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/4/780    most recent
01.ATV.0000209517.00220.cdv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryer, E. J.
Right arrow Articles by Kent, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryer, E. J.
Right arrow Articles by Kent, K. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:780.)
© 2006 American Heart Association, Inc.


Vascular Biology

PKC{delta} Is Necessary for Smad3 Expression and Transforming Growth Factor ß–Induced Fibronectin Synthesis in Vascular Smooth Muscle Cells

Evan J. Ryer; R. Patrick Hom; Kenji Sakakibara; Keiichi I. Nakayama; Keiko Nakayama; Peter L. Faries; Bo Liu; K. Craig Kent

From the Division of Vascular Surgery (E.J.R., R.P.H., K.S., P.L.F., B.L., K.C.K.), New York Presbyterian Hospital, Cornell University, Weill Medical School and Columbia University, College of Physicians and Surgeons, New York, NY; the Department of Molecular and Cellular Biology (K.I.N.), Medical Institute of Bioregulation, Kyushu University, Japan; and the Department of Developmental Biology (K.N.), Graduate School of Medicine, Tohoku University School of Medicine, Japan.

Correspondence to K. Craig Kent, MD, Department of Surgery, New York Presbyterian Hospital, Weill Medical College, Cornell University, 525 E 68th St, Room 707, New York, NY 10021. E-mail kckent{at}med.cornell.edu

Objective— The purpose of these studies is to investigate the mechanism by which transforming growth factor (TGF)ß1 regulates the synthesis of the extracellular matrix protein fibronectin (FN).

Methods and Results— TGFß1 elicited a time-dependent induction of FN protein and mRNA in A10 rat aortic smooth muscle cells (SMCs). Ectopic expression of Smad3 in A10 cells stimulated both basal and TGFß1-induced FN expression, whereas expression of Smad7 eliminated the TGFß response. Because TGFß activated PKC{delta} in SMCs, we tested the role of PKC{delta} in regulation of FN expression. Inhibition of PKC{delta} activity by rottlerin or dominant-negative adenovirus (AdPKC{delta} DN) blocked TGFß1’s induction of FN, whereas overexpression of PKC{delta} enhanced TGFß’s effect. Moreover, aortic SMCs isolated from PKC{delta}–/– mice exhibited diminished FN induction in response to TGFß. Furthermore, we found that Smad3 protein and mRNA were markedly reduced in AdPKC{delta} DN-treated A10 cells and in PKC{delta} null cells. Finally, restoring Smad3 in rottlerin-treated A10 and PKC{delta} null cells rescues the ability of TGFß to upregulate FN protein and mRNA expression.

Conclusion— Our data suggest that TGFß-activated PKC{delta} is critical to maintain normal expression of Smad3, which in turn is required for the induction of fibronectin. PKC{delta} represents a promising target for treating the fibroproliferative response after arterial injury.

The mechanism by which TGFß regulates the synthesis of fibronectin remains inconclusive. Our data suggest that TGFß-activated PKC{delta} is critical to maintain Smad3 levels, which in turn are required for fibronectin expression. Thus, PKC{delta} may serve as a novel therapeutic target to prevent the fibroproliferative response after arterial injury.


Key Words: extracellular matrix • fibronectin • intimal hyperplasia • protein kinase C delta • TGF beta




This article has been cited by other articles:


Home page
HypertensionHome page
H. Nakashima, G. D. Frank, H. Shirai, A. Hinoki, S. Higuchi, H. Ohtsu, K. Eguchi, A. Sanjay, M. E. Reyland, P. J. Dempsey, et al.
Novel Role of Protein Kinase C-{delta} Tyr311 Phosphorylation in Vascular Smooth Muscle Cell Hypertrophy by Angiotensin II
Hypertension, February 1, 2008; 51(2): 232 - 238.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Kamiya, K. Sakakibara, E. J. Ryer, R. P. Hom, E. B. Leof, K. C. Kent, and B. Liu
Phosphorylation of the Cyclic AMP Response Element Binding Protein Mediates Transforming Growth Factor {beta}-Induced Downregulation of Cyclin A in Vascular Smooth Muscle Cells
Mol. Cell. Biol., May 1, 2007; 27(9): 3489 - 3498.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Khan, A. Agrotis, and A. Bobik
Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury
Cardiovasc Res, May 1, 2007; 74(2): 223 - 234.
[Abstract] [Full Text] [PDF]